21 Febbraio 2023 In Comunicati, Notizie By Cinzia Sacchetti
COMUNICATO IMPORTANTE – CARENZA MEDICINALE
A tutti i pazienti in trattamento con Norditropin Nordiflex
Si prega di prestare la massima attenzione alla nota informativa allegata, inviata oggi dall’azienda Novo Nordisk riguardo la carenza del loro prodotto Norditropin Nordiflex a partire dal 15 aprile p.v. fino a febbraio 2024 e di consultare il proprio medico curante per l’eventuale cambio di terapia.
| Cookie | Durata | Descrizione |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
